Slingshot Biosciences, Inc. Partners with OLS
OLS to Distribute Synthetic Cells Throughout Germany, Austria, Switzerland and Italy

Dr. Andreas Friese

Bremen, JULY 8, 2022. SLINGSHOT BIOSCIENCES, INC. the developers of synthetic cells, today announced they have extended their distribution channel through a new agreement with OLS – OMNI Life Science. OLS is your partner for solutions in Flow Cytometry, Cell Culture, Cell Counting, Imaging, and Cell Analysis.

OLS’s network will provide us with the market penetration needed to reach our full sales potential. Slingshot Biosciences has considered many distribution partners and we are confident that OLS’s extensive knowledge in the field, prominent presence and large customer base will help us leverage our position in the flow cytometry market.

Jeffrey Kim, CEO & Founder, Slingshot Biosciences, Inc.

The agreement entitles OLS the rights to distribute and resell Slingshot Bio’s products in Germany, Austria, Switzerland, and Italy. Through OLS’s network of customers, Slingshot Bio will be able to establish its presence in the Germany, Austria, Switzerland, and Italy market with the well-established presence and expertise of OLS who has been selling into the flow cytometry industry for many years.

Slingshot Bio’s synthetic cellular controls provide consistent, precise, accurate control for research users in the flow cytometry space by mimicking blood properties as detected by flow cytometry. The ability to manufacture consistent controls for flow cytometry has been missing for decades and is now accurately reproducible with Slingshot Bio’s unique manufacturing platform.

Slingshot Bio’s synthetic cells greatly empower and round off our flow cytometry portfolio, which is a central pillar of OLS. Our company identity entails a great focus on innovation, precision, and reproducibility, and our newly established partnership with Slingshot Bio enables us to support labs during the entirety of their workflow while maintaining high scientific standards.

Andreas Friese, COO of OMNI Life Science

Founded in 2012, Slingshot Biosciences is a fast-growing life sciences company with a platform technology and paradigm-shifting mission to make synthetic cells the gold standard for all cell-based applications—including diagnostics, and adoptive cell therapy development and instrument calibration. Learn more at

Synthetic Cell Controls by Slingshot

Synthetic Cell Controls for Flow Cytometry by Slinghot - For Quality Control in drug development, diagnostics and cell therapy

Synthetic Cell Controls by Slingshot

Flow Cytometry NovoCyte

Multicolor research instruments for your flow cytometry lab

Flow Cytometry NovoCyte Instruments

Single Cell Dispenser Namocell

Effortless single cell sorting for Single Cell Genomics & Cell Line Development

Single Cell Dispenser Namocell


Dr. Thorsten Rieling

    Subscribe for our newsletter

    e-mail required
    By submitting my data and sending the registration, I agree to receive the newsletter ordered here by email. My data will not be disclosed to third parties. I can revoke this consent at any time. More detailed information in the Privacy Policy section
    OLS OMNI Life Science Your Partner in Cell Research
    Imprint | Privacy Policy | Terms and Conditions